Theriva Biologics (TOVX) Misses Q2 EPS by 1c

Theriva Biologics (NYSE: TOVX) reported Q2 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Theriva Biologics (TOVX) click here.

You May Also Be Interested In

• Intel (INTC) PT Lowered to $92 at Mizuho
• Asana shares tumble on weak third quarter earnings outlook
• Quanex (NX) Tops Q3 EPS by 14c; Offers Guidance